Phathom Pharmaceuticals, Inc. (PHAT)
8.30
-0.37
(-4.27%)
USD |
NASDAQ |
Sep 10, 12:27
Phathom Pharmaceuticals Max Drawdown (5Y) : 95.81% for Aug. 31, 2026
Max Drawdown (5Y) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| August 31, 2026 | 95.81% |
| July 31, 2026 | 95.81% |
| June 30, 2026 | 95.81% |
| May 31, 2026 | 95.81% |
| April 30, 2026 | 95.81% |
| March 31, 2026 | 95.81% |
| February 28, 2026 | 95.81% |
| January 31, 2026 | 95.81% |
| December 31, 2025 | 95.81% |
| November 30, 2025 | 95.81% |
| October 31, 2025 | 95.81% |
| September 30, 2025 | 95.81% |
| August 31, 2025 | 95.81% |
| July 31, 2025 | 95.81% |
| June 30, 2025 | 95.81% |
| May 31, 2025 | 95.81% |
| April 30, 2025 | 92.86% |
| March 31, 2025 | 92.27% |
| February 28, 2025 | 90.22% |
| January 31, 2025 | 89.03% |
| December 31, 2024 | 88.66% |
| November 30, 2024 | 88.66% |
| October 31, 2024 | 88.66% |
| September 30, 2024 | 88.66% |
| August 31, 2024 | 88.66% |
| Date | Value |
|---|---|
| July 31, 2024 | 88.66% |
| June 30, 2024 | 88.66% |
| May 31, 2024 | 88.66% |
| April 30, 2024 | 88.66% |
| March 31, 2024 | 88.66% |
| February 29, 2024 | 88.66% |
| January 31, 2024 | 88.66% |
| December 31, 2023 | 88.66% |
| November 30, 2023 | 88.66% |
| October 31, 2023 | 88.66% |
| September 30, 2023 | 88.66% |
| August 31, 2023 | 88.66% |
| July 31, 2023 | 88.66% |
| June 30, 2023 | 88.66% |
| May 31, 2023 | 88.66% |
| April 30, 2023 | 88.66% |
| March 31, 2023 | 88.66% |
| February 28, 2023 | 88.64% |
| January 31, 2023 | 88.64% |
| December 31, 2022 | 88.64% |
| November 30, 2022 | 88.64% |
| October 31, 2022 | 88.64% |
| September 30, 2022 | 88.64% |
| August 31, 2022 | 88.64% |
| July 31, 2022 | 88.64% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Max Drawdown (5Y) Benchmarks
| ANI Pharmaceuticals, Inc. | 72.96% |
| Corcept Therapeutics, Inc. | 71.85% |
| Veru, Inc. | 99.12% |
| Johnson & Johnson | 18.44% |
| Eli Lilly & Co. | 34.47% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -31.44 |
| Beta (5Y) | 0.5096 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 103.6% |
| Historical Sharpe Ratio (5Y) | -0.259 |
| Historical Sortino (5Y) | -0.6492 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 35.01% |